FDA
-
-
-
-
-
-
-
Shares of vaccine makers drop after FDA memo flags reports of child deaths
-
-
-
-
-
-
-
Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
-
-
-
-
-
-
-
Novavax (NVAX) Appoints Charles Newton to its Board
-
-
-
-
-
-
-
FDA misses Novavax (NVAX) Covid-19 Vaccine deciscion deadline - WSJ
-
-
-
-
-
-
-
Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million Milestone
-
-
-
-
-
-
-
Novavax (NVAX) Announces FDA Removed Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial
-
-
-
-
-
-
-
Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EU
-
327,765 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

